Company / Free Cash Flow per Share
GT Biopharma, Inc. Free Cash Flow per Share History
FY2012-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$18.52
FY2017
5-year range
-$18.52 / -$0.00
FY2013-FY2017
Trend
-854.2%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -854% YoY in FY2017, a notable deviation from the 5-year average annual change of -19391%.
Based on SEC 10-K filings.
-18.52 in FY2017.
Declined from $-0.74 to $-18.52 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- GT Biopharma, Inc.'s free cash flow per share has declined for 3 consecutive years.
- In FY2017, free cash flow per share decreased 854.2% year-over-year.
- Peak free cash flow per share was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2017 | -$18.52 | -854.2% |
| FY2016 | -$1.94 | -161.7% |
| FY2015 | -$0.74 | -96044.8% |
| FY2014 | -$0.00 | +61.0% |
| FY2013 | -$0.00 | +44.7% |
| FY2012 | -$0.00 | - |
| FY2011 | - | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026